224 related articles for article (PubMed ID: 25463086)
1. Non-HDL cholesterol is a better target for predicting periprocedural myocardial injury following percutaneous coronary intervention in type 2 diabetes.
Zeng RX; Li XL; Zhang MZ; Guo YL; Zhu CG; Guo LH; Li S; Zhang Y; Li JJ
Atherosclerosis; 2014 Dec; 237(2):536-43. PubMed ID: 25463086
[TBL] [Abstract][Full Text] [Related]
2. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
3. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
4. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
5. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
6. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B
Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052
[TBL] [Abstract][Full Text] [Related]
7. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
9. The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Qing P; Wu NQ; Xu B; Gao RL
Clin Cardiol; 2014 Sep; 37(9):558-65. PubMed ID: 25113039
[TBL] [Abstract][Full Text] [Related]
10. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
[TBL] [Abstract][Full Text] [Related]
11. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention.
Suzuki A; Ando H; Takashima H; Kumagai S; Kurita A; Waseda K; Suzuki Y; Mizuno T; Harada K; Uetani T; Takahashi H; Yoshikawa D; Ishii H; Murohara T; Amano T
EuroIntervention; 2014 Nov; 10(7):792-8. PubMed ID: 25415148
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids as a marker for predicting periprocedural myocardial injury after coronary intervention.
Wang Y; Zhang HW; Guo YL; Zhu CG; Wu NQ; Li JJ
Postgrad Med J; 2019 Jan; 95(1119):18-22. PubMed ID: 30700582
[TBL] [Abstract][Full Text] [Related]
13. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
Niccoli G; Sgueglia GA; Latib A; Crea F; Colombo A;
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E37-44. PubMed ID: 23813627
[TBL] [Abstract][Full Text] [Related]
14. Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
PLoS One; 2014; 9(7):e101719. PubMed ID: 24988213
[TBL] [Abstract][Full Text] [Related]
15. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
16. Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.
Verdoia M; Schaffer A; Barbieri L; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
Atherosclerosis; 2014 Sep; 236(1):169-74. PubMed ID: 25055060
[TBL] [Abstract][Full Text] [Related]
17. LDL cholesterol as a novel risk factor for contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
Liu YH; Liu Y; Chen JY; Zhou YL; Chen ZJ; Yu DQ; Luo JF; Li HL; He YT; Ye P; Ran P; Guo W; Tan N
Atherosclerosis; 2014 Dec; 237(2):453-9. PubMed ID: 25463073
[TBL] [Abstract][Full Text] [Related]
18. Association of serum laboratory parameters with periprocedural myocardial infarction after a primary percutaneous coronary intervention.
Deng Q; Hou J; Deng X; Zhong Z
Perfusion; 2023 Mar; 38(2):393-400. PubMed ID: 35038275
[TBL] [Abstract][Full Text] [Related]
19. Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention.
Harada K; Kikuchi R; Suzuki S; Tanaka A; Aoki T; Iwakawa N; Kojima H; Hirayama K; Mitsuda T; Sumi T; Negishi Y; Ishii H; Murohara T
Lipids Health Dis; 2018 Feb; 17(1):21. PubMed ID: 29391013
[TBL] [Abstract][Full Text] [Related]
20. Relationship of non-cardiac biomarkers with periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.
Zeng RX; Li JJ; Liao PD; Zhang MZ
Int J Cardiol; 2016 Oct; 221():726-33. PubMed ID: 27428312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
